Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Darolutamide
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Darolutamide NUBEQA
®
(300mg film-coated tablets)
Malignant disease and immunosuppression, Anti-androgens, 08.03.04.02
Links found
NICE TA1109: Darolutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer
NICE TA660: Darolutamide with androgen deprivation therapy for treating hormone-relapsed non-metastatic prostate cancer
NICE TA903: Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancer